Titlebook: Biomarkers in Inflammatory Bowel Diseases; Nik Sheng Ding,Peter De Cruz Textbook 2019 Springer Nature Switzerland AG 2019 Inflammatory Bow

到凝乳

書目名稱Biomarkers in Inflammatory Bowel Diseases影響因子(影響力)




書目名稱Biomarkers in Inflammatory Bowel Diseases影響因子(影響力)學(xué)科排名




書目名稱Biomarkers in Inflammatory Bowel Diseases網(wǎng)絡(luò)公開度




書目名稱Biomarkers in Inflammatory Bowel Diseases網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biomarkers in Inflammatory Bowel Diseases被引頻次




書目名稱Biomarkers in Inflammatory Bowel Diseases被引頻次學(xué)科排名




書目名稱Biomarkers in Inflammatory Bowel Diseases年度引用




書目名稱Biomarkers in Inflammatory Bowel Diseases年度引用學(xué)科排名




書目名稱Biomarkers in Inflammatory Bowel Diseases讀者反饋




書目名稱Biomarkers in Inflammatory Bowel Diseases讀者反饋學(xué)科排名

ABHOR

不能約

Clinical Trial Design to Facilitate Biomarker Discoveryent would be valuable. Data and materials collected in clinical trials are a valuable source for identification of predictive biomarkers or development of pharmacokinetic models. By using a dashboard system with an incorporated pharmacokinetic model, the exact medication dose a patient should receiv

有危險

Luminal Crohn’s Diseasertreating those with symptoms unrelated to their CD..Therefore, in addition to assessing clinical symptoms, there is a need to incorporate more objective markers of disease activity into the management of CD. In the pursuit of providing such information, a number of tools have been assessed in their

閑蕩

錢財

獸群

Refractory Proctitisst of the other potential topical agents is limited to open-labelled studies alone and thus requires a great deal more investigation. The use of systemic, immunomodulatory and biological agents in proctitis is the same as for left-sided and extensive UC. Therapy has undoubtedly improved over recent

鼓掌

The Role of Biomarkers in the?Ileal Anal Pouchlp guide clinicians. These biomarkers can help predict those that will develop pouchitis and may therefore be useful as a surveillance strategy to enable prompt treatment before symptoms of pouchitis develop..Despite their potential, no biomarker has been validated for its use in pouchitis, and the

Cervical-Spine

Soliloquy

https://doi.org/10.1007/978-3-642-96306-3rgical intervention in CD, compared with proximal disease extension, hospitalization, and colectomy in UC. Age at onset, disease phenotype characteristics (early disease course, behavior and localization/disease extension), smoking status, and accelerated treatment algorithms in early disease were r